Improving treatments for opioid use disorder
Select Late-Stage CMC, Non-clinical Studies, and Quality Programs to Accelerate NRS-033 Towards Pivotal Studies and Registration in Opioid Use Disorder
This study is looking for new and better ways to help people with opioid use disorder by creating more effective treatments that are easier to access and use, so that those struggling with addiction can have a better chance at recovery.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Nirsum Laboratories, INC. NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11158855 on NIH RePORTER |
What this research studies
This research focuses on addressing the opioid use disorder (OUD) crisis by developing new treatment options beyond the currently available medications. It aims to enhance the effectiveness and accessibility of medications for opioid use disorder, particularly targeting the limitations of existing treatments like injectable naltrexone. The approach involves non-clinical studies and quality programs to accelerate the development of new therapies that could provide better outcomes for patients struggling with addiction. By investigating innovative solutions, the research seeks to improve treatment retention and patient acceptance.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with opioid use disorder who are seeking effective treatment options.
Not a fit: Patients who are not struggling with opioid use disorder or those who have already found effective treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective and accessible treatments for individuals suffering from opioid use disorder.
How similar studies have performed: Other research has shown promise in developing new treatment approaches for opioid use disorder, indicating that innovative strategies can lead to significant advancements in patient care.
Where this research is happening
New York, United States
- Nirsum Laboratories, INC. — New York, United States (Active)
Researchers
- Principal investigator: Shah, Nikej — Nirsum Laboratories, INC.
- Study coordinator: Shah, Nikej
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.